Finerenone for chronic kidney disease in type 2 diabetes

   Rated 4 / 5 stars
Doctor holding kidney learning tool

Listen to the episode

Description

Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

In this episode:

  • Approved indication and PBS clinical criteria for finerenone
  • Safety profile and benefits of finerenone for type 2 diabetes patients with CKD
  • Initiation, dosing and titration process
  • What this treatment means for GPs and their type 2 diabetes patients with CKD

 

Total time: 7 mins

Last Updated: 9 Apr, 2024

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Expert panel - A/Prof Samantha Hocking, Prof John Dixon, facilitated by A/Prof Ralph Audehm

Expert panel - A/Prof Samantha Hocking, Prof John Dixon, facilitated by A/Prof Ralph Audehm

GLP-1 Prescribing Expert Panel Discussion

Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

Arrhythmia Management in Primary Care

Dr Rupert Hinds

Dr Rupert Hinds

Infant Allergy Cases

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sunil Badve

expert

Prof Sunil Badve

Nephrologist; Program Lead, Cardiometabolic Trials, Renal and Metabolic Program, The George Institute for Global Health; Senior Staff Specialist Nephrologist, St George Hospital

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.